The Effect of QVAR on Lung Functioning in Chronic Obstructive Pulmonary Disease
Status:
Terminated
Trial end date:
2005-02-01
Target enrollment:
Participant gender:
Summary
This is an investigator-sponsored research study to evaluate if treatment with HFA-134a
beclomethasone (QVAR) has an effect on peripheral (or outer) airway inflammation and airway
"remodeling" or scarring in subjects with COPD. Approximately 20 subjects with COPD will
participate for approximately 7 weeks, with 10 receiving an active (BDP) inhaler with
HFA-134a and 10 receiving a placebo.